Literature DB >> 21400547

First-ever atrial fibrillation documented after hemorrhagic or ischemic stroke: the role of the CHADS(2) score at the time of stroke.

Karin M Henriksson1, Bahman Farahmand, Signild Asberg, Andreas Terént, Nils Edvardsson.   

Abstract

BACKGROUND: The CHADS(2) score (C, congestive heart failure [CHF]; H, hypertension [HT]; A, age ≥75 y; D, diabetes mellitus; S(2) , prior stroke or transient ischemic attack) is used to assess the risk of ischemic stroke in patients with atrial fibrillation (AF). However, its role in patients without documented AF is not well explored. HYPOTHESIS: The goal of the current study was to explore if the incidence of hospitalization with first-ever AF after stroke increased with increasing CHADS(2) score.
METHODS: We identified 57636 patients with nonfatal stroke and no documented AF in the Swedish Stroke Register (Riks-Stroke) during 2001-2004 and followed them for a mean of 2.2 years through record linkage to the Inpatient and Cause of Death registers. Cox regression hazard models were used to estimate the relative risk (RR) of new AF following stroke and its association with different CHADS(2) scores.
RESULTS: Overall, 2769 patients were hospitalized with new AF (4.8%, 21.7 per 1000 person-years). The incidence increased from 9.6 per 1000 person-years in CHADS(2) score 0 to 42.7 in CHADS(2) score 6, conferring a RR of 4.2 (95% confidence interval [CI]: 2.5-6.8). For CHADS(2) scores 3-5, the RRs were approximately 3 (vs CHADS(2) score 0). Adjusted RRs were 1.9 (95% CI: 1.7-2.1) for CHF, 1.4 (95% CI: 1.3-1.5) for HT, 2.1 (95% CI: 2.0-2.3) for age ≥75 years, 0.9 (95% CI: 0.8-1.0) for diabetes, and 1.0 (95% CI: 0.91-1.07) for previous stroke. The risk of AF was higher in ischemic than in hemorrhagic stroke.
CONCLUSIONS: In this retrospective register study, the incidence of AF following stroke was strongly influenced by higher CHADS(2) scores where age ≥75 years, CHF, and HT were the contributing CHADS(2) components. 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21400547      PMCID: PMC6652505          DOI: 10.1002/clc.20869

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

1.  Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift?

Authors:  Antoni Bayés de Luna; Adrian Baranchuk; Manuel Martínez-Sellés; Pyotr G Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-12-16       Impact factor: 1.468

2.  Detection of paroxysmal atrial fibrillation in 994 patients with a cerebrovascular event by intermittent 21-day ECG-monitoring and 7-day continuous Holter-recording.

Authors:  Johanna Pennlert; Mårten Rosenqvist; Milos Kesek
Journal:  Ups J Med Sci       Date:  2022-05-05       Impact factor: 2.646

3.  Development of a Score to Predict the Paroxysmal Atrial Fibrillation in Stroke Patients: The Screening for Atrial Fibrillation Scale.

Authors:  Laura Amaya Pascasio; Miguel Quesada López; Juan Manuel García-Torrecillas; Antonio Arjona-Padillo; Patricia Martínez Sánchez
Journal:  Front Neurol       Date:  2022-06-28       Impact factor: 4.086

4.  Electrocardiographic and Echocardiographic predictors of paroxysmal atrial fibrillation detected after ischemic stroke.

Authors:  Maria A Baturova; Seth H Sheldon; Jonas Carlson; Peter A Brady; Grace Lin; Alejandro A Rabinstein; Paul A Friedman; Pyotr G Platonov
Journal:  BMC Cardiovasc Disord       Date:  2016-11-03       Impact factor: 2.298

5.  Atrial time and voltage dispersion are both needed to predict new-onset atrial fibrillation in ischemic stroke patients.

Authors:  Daniel Cortez; Maria Baturova; Arne Lindgren; Jonas Carlson; Yuri V Shubik; Bertil Olsson; Pyotr G Platonov
Journal:  BMC Cardiovasc Disord       Date:  2017-07-24       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.